Do Not Use Prednisone for Uncomplicated Influenza
Prednisone and other corticosteroids should NOT be used in patients with influenza, whether uncomplicated or severe, as they are associated with increased mortality, delayed viral clearance, and higher rates of secondary bacterial infections.
Evidence-Based Recommendation
The most recent WHO clinical practice guidelines (2024-2025) issue a conditional recommendation AGAINST corticosteroids in severe influenza 1, 2. No guideline recommends corticosteroids for uncomplicated influenza. The IDSA 2019 guidelines do not include corticosteroids in their treatment algorithm for influenza at any severity level 3.
Why Corticosteroids Are Harmful in Influenza
Multiple systematic reviews and meta-analyses consistently demonstrate harm:
- Increased mortality: Corticosteroid use is associated with nearly 4-fold increased odds of death (OR 3.90,95% CI 2.31-6.60) and adjusted hazard ratio of 1.49 for mortality 4
- Higher infection rates: 3-fold increased odds of hospital-acquired infections (OR 2.74-3.16) 4, 5
- Prolonged ICU stays: 4.78 days longer ICU duration and 3.82 days longer mechanical ventilation 5
- Delayed viral clearance: Corticosteroids impair the immune response needed to clear influenza virus 6
These findings hold across multiple studies examining both seasonal and pandemic influenza strains 7, 4, 5.
Critical Distinction: Influenza vs COVID-19
This is fundamentally different from COVID-19, where low-dose dexamethasone reduces mortality in hypoxic patients. The immunopathology differs between these viral infections—influenza requires intact immune responses for viral clearance, while severe COVID-19 involves hyperinflammation that benefits from immunosuppression 7. Do not extrapolate COVID-19 corticosteroid data to influenza patients.
What TO Do Instead
Per IDSA guidelines 3:
Start neuraminidase inhibitors immediately for:
- Any hospitalized patient with influenza
- Outpatients with severe/progressive illness
- High-risk patients (chronic conditions, immunocompromised, age <2 or ≥65 years, pregnant/postpartum)
Use oseltamivir 75 mg twice daily for 5 days as first-line treatment 3
Investigate and treat bacterial coinfection empirically in patients with:
- Severe initial presentation (extensive pneumonia, respiratory failure, hypotension)
- Clinical deterioration after initial improvement
- Failure to improve after 3-5 days of antivirals 3
Limited Exceptions (Not Uncomplicated Influenza)
The FDA label notes corticosteroids may be indicated for other concurrent conditions requiring steroids 8:
- Asthma or COPD exacerbation
- Septic shock (per sepsis protocols, not for influenza itself)
- Pre-existing conditions requiring chronic steroid therapy
Even in these scenarios, use the lowest effective dose for the shortest duration and recognize the increased infection risk 8.
Common Pitfall to Avoid
Do not reflexively prescribe corticosteroids for "severe inflammation" or respiratory distress in influenza patients. The observational data showing harm is remarkably consistent across studies, with most patients receiving high doses (>40 mg methylprednisolone equivalent daily) 4. While confounding by indication exists in observational studies, the consistency and magnitude of harm signal across multiple analyses supports avoiding routine use.